A phase 1/2 study of KSQ-004EX: Autologous tumor infiltrating lymphocytes, engineered to inactivate genes encoding SOCS1 and Regnase-1, in patients with select advanced solid tumors.

Authors: Rodabe Navroze Amaria, Scott Kopetz, Maria Pia Morelli, George R. Blumenschein, Mehmet Altan, Khaled Sanber, Amir A. Jazaeri, Michael A. Davies, Adi Diab, Isabella Claudia Glitza, Jennifer Leigh McQuade, Alexandra Ikeguchi, Hussein A. Tawbi, Chantale Bernatchez, Marie-Andree Forget, Cara L Haymaker, Karrie Wong, Erica Tobin, Micah J. Benson, Anna Truppel-Hartmann

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2675

Source: Full article

---

Abstract

TPS2675